Locally advanced, recurrent, or metastatic breast, gastric, endometrial, and selected other solid tumors with positive expression for HER-2 (3+)

2 total trials 1 recruiting

Filter these 2 trials by phase, country, sponsor and more.

Open in Search →

Showing 1–2 of 2 trials